EFGARTIGIMOD ALFA
EFGARTIGIMOD ALFA is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including VYVGART. Available dosage forms: injection, liquid.
Drug Details
- Generic Name
- EFGARTIGIMOD ALFA
- Brand Names
- VYVGART
- Application Number
- BLA761195
- Sponsor
- argenx US
- NDC Codes
- 2
- Dosage Forms
- INJECTION, LIQUID
- Routes
- INTRAVENOUS
- Active Ingredients
- EFGARTIGIMOD ALFA
Indications and Usage
1 INDICATIONS AND USAGE VYVGART is indicated for the treatment of adult patients with generalized myasthenia gravis (gMG). VYVGART is a neonatal Fc receptor blocker indicated for the treatment of adult patients with generalized myasthenia gravis (gMG). ( 1 )